Xtant Medical HoldingsXTNT -0.98%31 Median PS Value is $0.46 as of Jun. 25, 2026, which is 72% below its 10-year median of 1.62. GuruFocus rates XTNT with a GF Score™ of 31/100 and a GF Value™ of $0.62 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 338 Medical Devices & Instruments companies, Xtant Medical Holdings ranks worse than 71.01% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Xtant Medical Holdings's Median PS Value or its related term are showing as below:
XTNT'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.24 Med: 1.62 Max: 3.36
Current: 0.93
During the past 13 years, the highest Price to Median PS Value of Xtant Medical Holdings was 3.36. The lowest was 0.24. And the median was 1.62.
XTNT's Price-to-Median-PS-Value is ranked worse than 71.01% of 338
companies
in the Medical Devices & Instruments industry
Industry Median: 0.71
vs XTNT: 0.93
Xtant Medical Holdings (AMEX:XTNT) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Xtant Medical Holdings's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.4258
/
0.46
=
0.93
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xtant Medical Holdings Median PS Value Related Terms
Xtant Medical Holdings Median PS Value Historical Data
* Premium members only.
The historical data trend for Xtant Medical Holdings's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTNT vs MDAI, QTI, POSC: Median PS Value Comparison
For the Medical Devices subindustry, Xtant Medical Holdings's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Xtant Medical Holdings Price-to-Median-PS-Value vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Xtant Medical Holdings's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Xtant Medical Holdings's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 0.5589.
Xtant Medical Holdings's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.823.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Xtant Medical Holdings (XTNT) has a Median PS Value of $0.46 as of Jun. 25, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Xtant Medical Holdings and its competitors. This is 72% below median its historical median of 1.62. Over the past decade, Xtant Medical Holdings' Median PS Value has ranged from 0.24 to 3.36. According to the industry distribution chart, Xtant Medical Holdings ranks #240 out of 338 companies in the Medical Devices & Instruments industry, placing it in the top 71%.
Is Xtant Medical Holdings' Median PS Value too high?
Xtant Medical Holdings' current Median PS Value of $0.46 is 72% below median its 10-year median of 1.62. Over the past 10 years, this metric has ranged from a low of 0.24 to a high of 3.36. The Medical Devices & Instruments industry median Median PS Value is 0.71. Xtant Medical Holdings' value of $0.46 is 35.2% below this industry median. Based on the distribution chart, Xtant Medical Holdings ranks #240 out of 338 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Xtant Medical Holdings has a GF Score™ of 31/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Xtant Medical Holdings' Median PS Value compare to MDAI and QTI?
According to the Medical Devices & Instruments industry distribution chart, Xtant Medical Holdings ranks #240 out of 338 companies for Median PS Value. This places Xtant Medical Holdings in the lower half of its industry. The industry median Median PS Value is 0.71. Xtant Medical Holdings' value of $0.46 is 35.2% below this benchmark. Historically, Xtant Medical Holdings' own Median PS Value has ranged from 0.24 to 3.36 over the past decade. While the company's 10-year median is 1.62 vs. the industry median of 0.71, Xtant Medical Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Medical Devices & Instruments company?
The median Median PS Value among Medical Devices & Instruments companies is 0.71, based on 338 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xtant Medical Holdings's current Median PS Value of $0.46 is 35.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Xtant Medical Holdings and its competitors. For the Medical Devices & Instruments industry, the median Median PS Value is 0.71 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xtant Medical Holdings's current Median PS Value is $0.46, which is 72% below median its own 10-year median of 1.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xtant Medical Holdings stock overvalued right now?
Based on GuruFocus' analysis, Xtant Medical Holdings (XTNT) is currently considered Possible Value Trap. The stock's GF Value™ is $0.62, compared to a current price of $0.43 — trading 31.3% below its estimated fair value. The current Median PS Value is $0.46, which is 72% below median its 10-year median of 1.62 and 35.2% below the Medical Devices & Instruments industry median of 0.71. Xtant Medical Holdings' overall GF Score™ is 31/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Xtant Medical Holdings (XTNT), the current Median PS Value is $0.46 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Xtant Medical Holdings (XTNT) Overvalued in 2026?
Based on GuruFocus' analysis, Xtant Medical Holdings stock appears to be undervalued.
The current stock price of $0.43 is trading 31.3% below its estimated GF Value™ of $0.62.
GuruFocus considers Xtant Medical Holdings to be Possible Value Trap.
Key valuation signals for XTNT:
Median PS Value: $0.46 (72% below median its 10-year median of 1.62)
GF Value™: $0.62 vs. price of $0.43 (31.3% below fair value)
Industry Position: 35.2% below the Medical Devices & Instruments median (#240 of 338)
No single metric tells the full story. See the XTNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
31GF Score
Get the complete analysis for XTNT
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTNT has been successfully added to your 
